Fluent Biosciences Inc.

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 1

Forward Citations = 50

Loading Chart...

5 inventors (with patents filed for the assignee):

Robert Meltzer (5 out of 19 patents)

Sepehr Kiani (5 out of 57 patents)

Yi Xue (4 out of 15 patents)

4. Kristina Fontanez (4 out of 7 patents)

5. Christopher D'amato (1 out of 1 patent)

6. Desiree Schenk (0 patent)

6 patents: Sort by Forward Citations

1. 11976325 - Quantitative detection and analysis of molecules (2024-05-07),

2. 11866782 - Multi-omic analysis in monodisperse droplets (2024-01-09),

3. 11827936 - Methods and systems for single cell gene profiling (2023-11-28),

4. 11773452 - Single cell sequencing (2023-10-03),

5. 11512337 - Emulsion based drug screening (2022-11-29),

6. 11104961 - Single cell sequencing (2021-08-31),

Company Overview

Fluent Biosciences is a biotechnology company that develops innovative liquid biopsy technologies for cancer detection and monitoring. Their proprietary platform allows for highly sensitive and specific detection of cancer biomarkers in blood samples, enabling early diagnosis and personalized treatment strategies. Fluent Biosciences is dedicated to improving patient outcomes and revolutionizing cancer care through their cutting-edge technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#53 in Watertown, MA

#2,548 in Massachusetts

#45,030 in US

Watertown, MA, United States of America

Fluent Biosciences Inc.

Forward Citations = 50

5 inventors:

Robert Meltzer (5 out of 19 patents)

Sepehr Kiani (5 out of 57 patents)

Yi Xue (4 out of 15 patents)

4. Kristina Fontanez (4 out of 7 patents)

5. Christopher D'amato (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fluent Biosciences Inc.. Retrieved from https://idiyas.com/company/fluent-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]